Consistently, the expression of phosphorylated NF-κB p65 was also reduced in a time-dependent manner when treated with JZL184 (Fig. 4d), suggesting that MAGL could affect the activation of NF-κB signaling in HCC cells. This evidence concerns the gene MGLL and hepatocellular carcinoma.